Vident Advisory, LLC Bio Rad Laboratories, Inc. Transaction History

Vident Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $23,070 - $29,195	-86 Reduced 10.17%	760 $208 Million
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $24,328 - $28,159	-80 Reduced 8.64%	846 $293 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $10,774 - $14,601	-40 Reduced 4.14%	926 $299 Million
Q3 2023 Feb 21, 2024	BUY	$350.25 - $422.63 $14,010 - $16,905	40 Added 4.32%	966 $346 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $338,341 - $408,260	966 New	966 $346 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.